{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:16:46Z","timestamp":1789514206183,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10792-016-0239-y","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T13:51:35Z","timestamp":1462542695000},"page":"139-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis"],"prefix":"10.1007","volume":"37","author":[{"given":"Serpil","family":"Yazgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesibe Karahan","family":"Ye\u015fil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Erdem","family":"Baki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Gencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"key":"239_CR1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","volume":"74","author":"C Stolwijk","year":"2015","unstructured":"Stolwijk C, van Tubergen A, Castillo-Ortiz JD et al (2015) Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis 74:65\u201373","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"239_CR2","first-page":"1","volume":"18","author":"MA Khan","year":"1992","unstructured":"Khan MA (1992) An overview of clinical spectrum and heterogeneity of spondyloarthropathies. Rheum Dis Clin North Am 18(1):1\u201310 (Review)","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"239_CR3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0889-857X(21)00714-6","volume":"18","author":"JT Rosenbaum","year":"1992","unstructured":"Rosenbaum JT (1992) Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am. 18(1):143\u2013151 (Review)","journal-title":"Rheum Dis Clin North Am."},{"issue":"1","key":"239_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molimm.2013.06.013","volume":"57","author":"PC Robinson","year":"2014","unstructured":"Robinson PC, Brown MA (2014) Genetics of ankylosing spondylitis. Mol Immunol 57(1):2\u201311","journal-title":"Mol Immunol"},{"issue":"1","key":"239_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semarthrit.2012.12.005","volume":"43","author":"Q Yao","year":"2013","unstructured":"Yao Q (2013) Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases. Semin Arthritis Rheum 43(1):125\u2013130","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"239_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00002281-200207000-00001","volume":"14","author":"TM Martin","year":"2002","unstructured":"Martin TM, Smith JR, Rosenbaum JT (2002) Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathies. Curr Opin Rheumatol 14(4):337\u2013341 (Review)","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"239_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00393-009-0576-6","volume":"69","author":"R Max","year":"2010","unstructured":"Max R, Lorenz HM, Mackensen F (2010) Ocular involvement in spondyloarthropathies: HLA B27 associated uveitis. Z Rheumatol 69(5):397\u2013402 (Review)","journal-title":"Z Rheumatol"},{"issue":"6","key":"239_CR8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0049-0172(95)80011-5","volume":"24","author":"DJ Careless","year":"1995","unstructured":"Careless DJ, Inman RD (1995) Acute anterior uveitis: clinical and experimental aspects. Semin Arthritis Rheum. 24(6):432\u2013441 (Review)","journal-title":"Semin Arthritis Rheum."},{"issue":"4","key":"239_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ajo.2010.04.031","volume":"150","author":"AR Loh","year":"2010","unstructured":"Loh AR, Acharya NR (2010) Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol 150(4):534\u2013542. doi: 10.1016\/j.ajo.2010.04.031","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"239_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jfo.2010.07.002","volume":"34","author":"P Labalette","year":"2011","unstructured":"Labalette P (2011) Refractory anterior uveitis. J Fr Ophtalmol 34(2):122\u2013126","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"239_CR11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/jop.2008.0087","volume":"25","author":"YS Byun","year":"2009","unstructured":"Byun YS, Park YH (2009) Complications and safety profile of posterior subtenon injection of triamcinolone acetonide. J Ocul Pharmacol Ther 25(2):159\u2013162","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"239_CR12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/ceo.12433","volume":"43","author":"JT Fitzgerald","year":"2015","unstructured":"Fitzgerald JT, Saunders L, Ridge B, White AJ, Goldberg I, Clark B, Mills RA, Craig JE (2015) Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit. Clin Exp Ophthalmol 43(3):234\u2013238","journal-title":"Clin Exp Ophthalmol"},{"key":"239_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2015.07.001","volume":"61","author":"CS Foster","year":"2015","unstructured":"Foster CS, Kothari S, Anesi SD, Vitale AT, Chu D, Metzinger JL, Cer\u00f3n O (2015) The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management. Surv Ophthalmol 61:1\u201317","journal-title":"Surv Ophthalmol"},{"issue":"Pt 3A","key":"239_CR14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2000.84","volume":"14","author":"JM Benitez-Del-Castillo","year":"2000","unstructured":"Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T et al (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye (Lond) 14(Pt 3A):340\u2013343","journal-title":"Eye (Lond)"},{"issue":"11","key":"239_CR15","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","volume":"42","author":"DO Clegg","year":"1999","unstructured":"Clegg DO, Reda DJ, Abdellatif M (1999) Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondyloarthropathies: a Department of Veterans Affairs cooperative study. Arthritis Rheum 42(11):2325\u20132329","journal-title":"Arthritis Rheum"},{"issue":"2","key":"239_CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ncprheum0097","volume":"2","author":"G Levy-Clarke","year":"2006","unstructured":"Levy-Clarke G, Nussenblatt R (2006) Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis? Nat Clin Pract Rheumatol 2(2):72\u201373","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"12","key":"239_CR17","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2006.052092","volume":"65","author":"S Guignard","year":"2006","unstructured":"Guignard S, Gossec L, Salliot C et al (2006) Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondyloarthropathy: a retrospective study. Ann Rheum Dis 65(12):1631\u20131634","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"239_CR18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509\u2013516 (Review)","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"239_CR19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, R\u00f8devand E, Holck P et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 68(5):696\u2013701","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"239_CR20","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1002\/art.20754","volume":"50","author":"JT Rosenbaum","year":"2004","unstructured":"Rosenbaum JT (2004) Effect of etanercept on iritis in patients with ankylosing spondylitis. Arthritis Rheum 50(11):3736\u20133737","journal-title":"Arthritis Rheum"},{"issue":"12","key":"239_CR21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0248-8663(03)00140-1","volume":"24","author":"B Bodaghi","year":"2003","unstructured":"Bodaghi B, Wechsler B, Du-Boutin LT et al (2003) Chronic severe uveitis: classification, search for etiology and therapeutic approach. Rev Med Interne 24(12):794\u2013802. (French)","journal-title":"Rev Med Interne"},{"issue":"5","key":"239_CR22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/ard.2011.154799","volume":"71","author":"J Braun","year":"2012","unstructured":"Braun J, Deodhar A, Inman RD et al (2012) Golimumab administered subcutaneously every 4\u00a0weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study. Ann Rheum Dis 71(5):661\u2013667","journal-title":"Ann Rheum Dis"},{"key":"239_CR23","doi-asserted-by":"crossref","first-page":"717598","DOI":"10.1155\/2014\/717598","volume":"2014","author":"M Cordero-Coma","year":"2014","unstructured":"Cordero-Coma M, Calvo-R\u00edo V, Ad\u00e1n A, Blanco R, \u00c1lvarez-Castro C, Mesquida M, Calleja S, Gonz\u00e1lez-Gay MA, Ru\u00edz de Morales JG (2014) Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience. Mediat Inflamm 2014:717598","journal-title":"Mediat Inflamm"},{"issue":"2","key":"239_CR24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09273948.2013.844265","volume":"22","author":"E Miserocchi","year":"2014","unstructured":"Miserocchi E, Modorati G, Pontikaki I, Meroni PL, Gerloni V (2014) Long-term treatment with golimumab for severe uveitis. Ocul Immunol Inflamm 22(2):90\u201395","journal-title":"Ocul Immunol Inflamm"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-016-0239-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0239-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T05:13:19Z","timestamp":1655701999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-016-0239-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1007\/s10792-016-0239-y","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,6]]}}}